16/2/2021
The second edition of our newsletter looks at the latest developments from Cambridge Raman Imaging, Fieldwork Robotics, Elute Intelligence and Nandi Proteins. You can also learn more about The Vaccine Group’s approach to tackling COVID-19, why Exscientia CEO Andrew Hopkins thinks AI-driven drug discovery is at a tipping point and how our partner university NOVA University, NOVA School of Science and Technology, is combating cork taint.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
These cookies allow us to count visits and traffic so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular, and see how visitors move around the site.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
More information about our Cookie Policy